FilingsTodayHCA Healthcare
At a glance
HCA Healthcare reported 2025 revenue of $75.6B, up 7.1% from $70.6B in 2024. Over 4 years since 2021 ($58.75B), that is growth of about 6.5% a year. 2025 was the highest revenue year in this period.
In the last 12 months 5 insiders reported 0 open-market purchases and 6 sales ($31.1M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $21.5M by CEO Samuel N Hazen on Feb 5, 2026.
HCA Healthcare filed 12 current reports (Form 8-K) in the last 12 months, most often for results of operations (5), new financial obligation (3), officer or director change (2) and material agreement (2). The latest officer or director change was reported on Jun 18, 2026. It reported a material agreement or a completed acquisition or disposal 2 times.
3 of the 20 investors tracked here held HCA Healthcare at the last quarter end, worth $317.1M combined. It is the largest weight for Bridgewater Associates (0.3% of its portfolio), followed by National Pension Service (Korea) (0.1%). New this quarter: Renaissance Technologies. Added: Bridgewater Associates.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $6.96B | $5.64B | $5.24B | $5.76B | $6.78B |
| Diluted EPS | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 |
| Dividend per share | $1.92 | $2.24 | $2.40 | $2.64 | $2.88 |
Fiscal year ends Dec 31
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined